The Mononucleosis Diagnostic Market is on track for significant expansion, with a projected market size of USD 3.2 billion by 2030. This substantial increase from USD 1.7 billion in 2022 reflects a Compound Annual Growth Rate (CAGR) of 8.6% over the forecast period (2023-2030). Key Players The major key players are Daiichi, Digene, Hemagen, Meridian, Gene-Tac, Biotest, Abbott...